• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1999-2009 年新西兰和英国痛风住院患者及其合并症分析。

Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999-2009.

机构信息

University of Queensland Diamantina Institute, Princess Alexandra Hospital, Ipswich Road, Woolloogabba, Queensland 4102, Australia.

出版信息

Rheumatology (Oxford). 2013 Jan;52(1):118-26. doi: 10.1093/rheumatology/kes253. Epub 2012 Sep 18.

DOI:10.1093/rheumatology/kes253
PMID:22989425
Abstract

OBJECTIVES

To describe the national demographics, comorbidities and mortality of admissions associated with gout in New Zealand (NZ) from 1999 to 2009 and compare this with English gout admission data from the same period.

METHODS

The characteristics of all admissions due to or complicated by gout in NZ from 1999 to 2009 were analysed. These findings were then compared with the wider NZ population and the English National Health Service (NHS) gout admission rates from 1999 to 2009.

RESULTS

There were 10 241 admissions due to gout (group A) and 34 318 admissions complicated by gout (group B) in NZ from 1999 to 2009. There were 32 741 admissions due to gout in England over the same period. Gout admissions rose at 5.5% per year in NZ and at 7.2% per year in England over the study period. NZ gout patients admitted to hospital were more likely to be Māori or a Pacific Islander and had 3-7 comorbidities. Multiple admissions were common with 1479 NZ gout patients admitted more than once. Comorbidities varied between the NZ groups A and B: hypertension (19-39%), renal disease (16-27%) and diabetes mellitus (20-27%) were common. Heart failure (27.6%) and cardiovascular disease (39.1%) were common in those who had gout complicating their hospital admission. This group also had poorer survival compared with those admitted primarily for gout.

CONCLUSION

This is the first study to describe the epidemiology of admissions associated with gout across an entire country. Admissions are rising in both countries studied and those admitted in NZ have a high rate of comorbidity and re-admission.

摘要

目的

描述新西兰(NZ)1999 年至 2009 年与痛风相关的住院患者的全国人口统计学、合并症和死亡率,并将其与同期英国痛风住院数据进行比较。

方法

分析了 1999 年至 2009 年期间 NZ 所有因痛风或并发痛风的住院患者的特征。然后将这些发现与更广泛的 NZ 人群和同期英国国民保健制度(NHS)痛风住院率进行比较。

结果

1999 年至 2009 年期间,NZ 共有 10241 例因痛风(A 组)和 34318 例因痛风并发的住院患者(B 组)。同期,英国共有 32741 例因痛风住院。在研究期间,NZ 痛风住院人数每年增长 5.5%,英国每年增长 7.2%。在 NZ 住院的痛风患者更有可能是毛利人或太平洋岛民,且有 3-7 种合并症。多次住院很常见,1479 名 NZ 痛风患者多次住院。A 组和 B 组的合并症不同:高血压(19-39%)、肾脏疾病(16-27%)和糖尿病(20-27%)较为常见。心力衰竭(27.6%)和心血管疾病(39.1%)在那些因痛风并发住院的患者中较为常见。与那些主要因痛风住院的患者相比,这些患者的存活率较低。

结论

这是第一项描述整个国家痛风相关住院患者流行病学的研究。在这两个研究国家,住院人数都在增加,而 NZ 住院患者的合并症和再入院率较高。

相似文献

1
Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999-2009.1999-2009 年新西兰和英国痛风住院患者及其合并症分析。
Rheumatology (Oxford). 2013 Jan;52(1):118-26. doi: 10.1093/rheumatology/kes253. Epub 2012 Sep 18.
2
Factors associated with recurrent hospital admissions for gout: a case-control study.痛风再入院相关因素:一项病例对照研究。
J Clin Rheumatol. 2009 Sep;15(6):271-4. doi: 10.1097/RHU.0b013e3181b562f8.
3
Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988-91.1988 - 1991年新西兰因充血性心力衰竭导致的住院和死亡情况。
N Z Med J. 1995 Nov 24;108(1012):473-5.
4
Revisiting comorbidities in gout: a cluster analysis.重新审视痛风的共病情况:聚类分析。
Ann Rheum Dis. 2015 Jan;74(1):142-7. doi: 10.1136/annrheumdis-2013-203779. Epub 2013 Oct 9.
5
Acutely decompensated heart failure: characteristics of hospitalized patients and opportunities to improve their care.急性失代偿性心力衰竭:住院患者的特征及改善其治疗的机会
Rev Port Cardiol. 2006 Jan;25(1):13-27.
6
Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice.新西兰成年人群中的痛风、糖尿病和心血管疾病:共患病率及其对临床实践的影响。
N Z Med J. 2012 Jan 25;126(1368):53-64.
7
National prevalence of gout derived from administrative health data in Aotearoa New Zealand.新西兰奥塔哥地区基于行政健康数据的痛风全国患病率。
Rheumatology (Oxford). 2012 May;51(5):901-9. doi: 10.1093/rheumatology/ker361. Epub 2012 Jan 16.
8
[Epidemiology of severe chronic renal insufficiency in Burkina Faso].[布基纳法索严重慢性肾功能不全的流行病学]
Sante. 1997 Nov-Dec;7(6):379-83.
9
Epidemiology of inpatient gout in Australia and New Zealand: temporal trends, comorbidities and gout flare site.澳大利亚和新西兰住院痛风患者的流行病学:时间趋势、合并症及痛风发作部位
Int J Rheum Dis. 2017 Jun;20(6):779-784. doi: 10.1111/1756-185X.12941. Epub 2016 Jul 26.
10
Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.预测5年内心血管疾病和中风的人群水平风险降低对急性住院率的影响——一项试点研究。
Public Health. 2006 Dec;120(12):1140-8. doi: 10.1016/j.puhe.2006.10.012. Epub 2006 Nov 3.

引用本文的文献

1
Hyperuricaemia and gout in the Pacific.太平洋地区的高尿酸血症与痛风
Nat Rev Rheumatol. 2025 Apr;21(4):197-210. doi: 10.1038/s41584-025-01228-7. Epub 2025 Mar 11.
2
Meta-analysis and systematic review of gout prevalence in the heart/lung transplantation population.心脏/肺移植人群痛风患病率的荟萃分析与系统评价
Front Transplant. 2024 May 20;3:1356058. doi: 10.3389/frtra.2024.1356058. eCollection 2024.
3
Burden of gout among different WHO regions, 1990-2019: estimates from the global burden of disease study.1990-2019 年不同世界卫生组织区域的痛风负担:全球疾病负担研究的估计。
Sci Rep. 2024 Jul 10;14(1):15953. doi: 10.1038/s41598-024-61616-z.
4
Exploring the Relationship of SARS-CoV-2 and Uric Acid Levels With a Focus on Gout Patients: A Scoping Review.探索新型冠状病毒肺炎与尿酸水平的关系,重点关注痛风患者:一项范围综述
Cureus. 2024 Mar 28;16(3):e57138. doi: 10.7759/cureus.57138. eCollection 2024 Mar.
5
Prevalence of Diabetes in Patients with Hyperuricemia and Gout: A Systematic Review and Meta-analysis.高尿酸血症及痛风患者中糖尿病的患病率:一项系统评价和荟萃分析。
Curr Diab Rep. 2023 Jun;23(6):103-117. doi: 10.1007/s11892-023-01506-2. Epub 2023 Apr 26.
6
A glance into the future of gout.痛风的未来展望
Ther Adv Musculoskelet Dis. 2022 Jul 28;14:1759720X221114098. doi: 10.1177/1759720X221114098. eCollection 2022.
7
Representation Rate and Management of Gout for Patients Discharged From Emergency Departments in Illawarra Shoalhaven Local Health District.伊拉瓦拉肖尔黑文地区卫生区急诊科出院痛风患者的表征率及管理情况
Clin Med Insights Arthritis Musculoskelet Disord. 2022 May 23;15:11795441221097351. doi: 10.1177/11795441221097351. eCollection 2022.
8
Hospital admission risk stratification of patients with gout presenting to the emergency department.急诊科就诊痛风患者的住院风险分层。
Clin Rheumatol. 2022 Jun;41(6):1801-1807. doi: 10.1007/s10067-021-05902-5. Epub 2022 Jan 1.
9
Anti-gout Medications and Risk of Cardiovascular Disease: A Nested Case-Control Study.抗痛风药物与心血管疾病风险:一项巢式病例对照研究。
Front Med (Lausanne). 2021 Oct 18;8:739680. doi: 10.3389/fmed.2021.739680. eCollection 2021.
10
Healthcare-related impact of gout in hospitalized patients in Spain.西班牙住院患者痛风的医疗保健相关影响。
Sci Rep. 2021 Jun 24;11(1):13287. doi: 10.1038/s41598-021-92673-3.